Érick Gamelin
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 101
- Colorectal Cancer Treatments and Studies 57
- Cancer Treatment and Pharmacology 30
- Cancer Immunotherapy and Biomarkers 9
- Cancer-related Molecular Pathways 8
-
- Cancer therapeutics and mechanisms 12
- Co-authors
- M. Boisdron‐Celle (43 shared papers)Alain Morel (31 shared papers)Laurence Gamelin (8 shared papers)R. Delva (9 shared papers)S. Brienza (8 shared papers)Olivier Coqueret (10 shared papers)Norbert Ifrah (5 shared papers)Arnaud Vigneron (6 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Cancer Research (8 papers)Annals of Oncology (7 papers)European Journal of Cancer (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Érick Gamelin
137 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 115
- Oncology 3.7k
- Hepatology 354
- Dermatology 335
- Pharmacology 306
- Immunology 657
Countries citing papers authored by Érick Gamelin
This map shows the geographic impact of Érick Gamelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Érick Gamelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Érick Gamelin more than expected).
Fields of papers citing papers by Érick Gamelin
This network shows the impact of papers produced by Érick Gamelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Érick Gamelin. The network helps show where Érick Gamelin may publish in the future.
Co-authors
The 25 scholars most cited alongside Érick Gamelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical pharmacokinetics of oxaliplatin: a critical review. | 2000 | 391 |
| 2 | 2007 | 386 | |
| 3 | 1996 | 332 | |
| 4 | 2001 | 270 | |
| 5 | 2004 | 259 | |
| 6 | 2009 | 253 | |
| 7 | 2002 | 252 | |
| 8 | 2008 | 249 | |
| 9 | 2004 | 211 | |
| 10 | 1996 | 180 | |
| 11 | 2006 | 176 | |
| 12 | 2005 | 172 | |
| 13 | 1999 | 168 | |
| 14 | 2006 | 167 | |
| 15 | 1995 | 163 | |
| 16 | 2006 | 107 | |
| 17 | 2007 | 105 | |
| 18 | 2011 | 103 | |
| 19 | 2011 | 80 | |
| 20 | 2007 | 79 |
About Érick Gamelin
Érick Gamelin is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Cell Biology, having authored 138 papers that have together received 6.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (57 papers), Cancer Treatment and Pharmacology (30 papers), Cancer therapeutics and mechanisms (12 papers), Microtubule and mitosis dynamics (11 papers), Gastric Cancer Management and Outcomes (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer-related Molecular Pathways (8 papers). The work is most often cited by research in Oncology (3.7k citations), Hepatology (354 citations), Dermatology (335 citations), Pharmacology (306 citations) and Immunology (657 citations). Érick Gamelin has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include M. Boisdron‐Celle, Alain Morel, Laurence Gamelin, R. Delva, S. Brienza, Olivier Coqueret, Norbert Ifrah, Arnaud Vigneron, Stefan Quasthoff and Laura Bossi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, European Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.